CVS Health Corp's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 40/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 91.70.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CVS Health Corp's Score
Industry at a Glance
Industry Ranking
40 / 78
Overall Ranking
187 / 4592
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
29
analysts
Buy
Current Rating
91.697
Target Price
+19.82%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CVS Health Corp Highlights
StrengthsRisks
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 372.81B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.61% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 73.28%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 73.28%.
Overvalued
The company’s latest PE is 211.34, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.14B shares, increasing 0.02% quarter-over-quarter.
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Ticker SymbolCVS
CompanyCVS Health Corp
CEOJoyner (J. David David)
Websitehttps://cvshealth.com/
FAQs
What is the current price of CVS Health Corp (CVS)?
The current price of CVS Health Corp (CVS) is 79.675.
What is the symbol of CVS Health Corp?
The ticker symbol of CVS Health Corp is CVS.
What is the 52-week high of CVS Health Corp?
The 52-week high of CVS Health Corp is 85.150.
What is the 52-week low of CVS Health Corp?
The 52-week low of CVS Health Corp is 43.560.
What is the market capitalization of CVS Health Corp?
The market capitalization of CVS Health Corp is 101.19B.
What is the net income of CVS Health Corp?
The net income of CVS Health Corp is 4.61B.
Is CVS Health Corp (CVS) currently rated as Buy, Hold, or Sell?
According to analysts, CVS Health Corp (CVS) has an overall rating of Buy, with a price target of 91.697.
What is the Earnings Per Share (EPS TTM) of CVS Health Corp (CVS)?
The Earnings Per Share (EPS TTM) of CVS Health Corp (CVS) is 0.376.